Hiroshi Fujiwara

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase <scp>II</scp> study

Takashi Ishida, Tatsuro Jo, Shigeki Takemoto et al. · British Journal of Haematology · 2015 · 262 citations · Full text

Medicine, Oncology, Pharmacology +17

Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR

Sachiko Okamoto, Junichi Mineno, Hiroaki Ikeda et al. · Cancer Research · 2009 · 184 citations

Medicine, Immunology, Oncology +17

Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

Isao Tawara, Shinichi Kageyama, Yoshihiro Miyahara et al. · Blood · 2017 · 168 citations · Full text

Life Sciences, Immunology, Oncology +12

Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety

Toshiki Ochi, Hiroshi Fujiwara, Sachiko Okamoto et al. · Blood · 2011 · 120 citations

Life Sciences, Immunology, Oncology +17

Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination

Yasushi Akahori, Linan Wang, Motohiro Yoneyama et al. · Blood · 2018 · 107 citations · Full text

Medicine, Immunology, Oncology +16